Tag: Maxwell Biomedical

Maxwell Biomedical Completes Acquisition of Cardialen’s Assets

Financial by 0 comments

Acquisition expands the Maxwell Biomedical product and intellectual property portfolio. SAN DIEGO, Dec. 14, 2022 /PRNewswire/ — Maxwell Biomedical announced today that it has completed the acquisition of Cardialen’s assets. Cardialen, a Minneapolis, MN based company developed MultiPulse™ Therapy (MPT™), a low-energy defibrillation and cardioversion […]

Continue Reading →

Maxwell Biomedical announced that it has initiated its First-In-Human Clinical Trial “Initial Experience with Spatial Resynchronization Therapy in Patients with Atrial Fibrillation (SR-TheAF)”

Rhythm by 0 comments

Maxwell Biomedical announced that it has initiated its First-In-Human Clinical Trial “Initial Experience with Spatial Resynchronization Therapy in Patients with Atrial Fibrillation (SR-TheAF)” continue reading the article here.

Continue Reading →